These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28511165)

  • 21. Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005.
    Sahm DF; Brown NP; Draghi DC; Evangelista AT; Yee YC; Thornsberry C
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):8-15. PubMed ID: 18931466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Castanheira M; Gales AC; Pignatari AC; Jones RN; Sader HS
    Microb Drug Resist; 2006; 12(2):91-8. PubMed ID: 16922623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quinolone resistance among pneumococci: therapeutic and diagnostic implications.
    Low DE
    Clin Infect Dis; 2004 May; 38 Suppl 4():S357-62. PubMed ID: 15127370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive pneumococci before the introduction of pneumococcal conjugate vaccine in Turkey: antimicrobial susceptibility, serotype distribution, and molecular identification of macrolide resistance.
    Altun HU; Hascelik G; Gür D; Eser ÖK
    J Chemother; 2015 Feb; 27(2):74-9. PubMed ID: 24548097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.
    Chen DK; McGeer A; de Azavedo JC; Low DE
    N Engl J Med; 1999 Jul; 341(4):233-9. PubMed ID: 10413735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Respiratory tract infection: epidemiology and surveillance.
    Jacobs MR
    J Chemother; 1997 May; 9 Suppl 3():10-7. PubMed ID: 9248976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development.
    Simoens S; Verhaegen J; Laekeman G; Peetermans WE
    Int J Antimicrob Agents; 2005 Jul; 26(1):62-8. PubMed ID: 15963695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of bacterial resistance to macrolides.
    Halpern MT; Schmier JK; Snyder LM; Asche C; Sarocco PW; Lavin B; Nieman R; Mandell LA
    J Antimicrob Chemother; 2005 May; 55(5):748-57. PubMed ID: 15772147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study.
    von Gottberg A; Klugman KP; Cohen C; Wolter N; de Gouveia L; du Plessis M; Mpembe R; Quan V; Whitelaw A; Hoffmann R; Govender N; Meiring S; Smith AM; Schrag S;
    Lancet; 2008 Mar; 371(9618):1108-13. PubMed ID: 18359074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005.
    Karlowsky JA; Lagacé-Wiens PR; Low DE; Zhanel GG
    Int J Antimicrob Agents; 2009 Oct; 34(4):375-9. PubMed ID: 19560902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial therapy for chronic bacterial prostatitis.
    Perletti G; Marras E; Wagenlehner FM; Magri V
    Cochrane Database Syst Rev; 2013 Aug; (8):CD009071. PubMed ID: 23934982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and pharmacodynamic predictors of antimicrobial efficacy: moxifloxacin and Streptococcus pneumoniae.
    Schentag JJ
    J Chemother; 2002 Feb; 14 Suppl 2():13-21. PubMed ID: 12003136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States.
    Doern GV
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S187-92. PubMed ID: 11524718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of macrolides in treatment of upper respiratory tract infections.
    Wierzbowski AK; Hoban DJ; Hisanaga T; DeCorby M; Zhanel GG
    Curr Allergy Asthma Rep; 2006 Mar; 6(2):171-81. PubMed ID: 16566868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guideline for the management of upper respiratory tract infections.
    Brink AJ; Cotton MF; Feldman C; Geffen L; Hendson W; Hockman MH; Maartens G; Madhi SA; Mutua-Mpungu M; Swingler GH;
    S Afr Med J; 2004 Jun; 94(6 Pt 2):475-83. PubMed ID: 15244257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.
    Morrissey I; Colclough A; Northwood J
    Int J Antimicrob Agents; 2007 Oct; 30(4):345-51. PubMed ID: 17643269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the relevance of antimicrobial resistance on the outcome of community-acquired pneumonia caused by Streptococcus pneumoniae? (should macrolide monotherapy be used for mild pneumonia?).
    Low DE
    Infect Dis Clin North Am; 2013 Mar; 27(1):87-97. PubMed ID: 23398867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides.
    Cornick JE; Bentley SD
    Microbes Infect; 2012 Jul; 14(7-8):573-83. PubMed ID: 22342898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia: pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoniae.
    Noreddin AM; Hoban DJ; Zhanel GG
    Int J Antimicrob Agents; 2005 Aug; 26(2):120-5. PubMed ID: 16046101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Streptococcus pneumoniae: low frequency of penicillin resistance and high resistance to trimethoprim-sulfamethoxazole in nasopharyngeal isolates from children in a rural area in Mexico.
    Miranda Novales MG; Solorzano Santos F; Guiscafre Gallardo H; Leaños Miranda B; Echaniz Aviles G; Carnalla Barajas MN; Palafox Torres M; Muñoz Hernandez O
    Arch Med Res; 1997; 28(4):559-63. PubMed ID: 9428584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.